サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1786578

便潜血検査の世界市場

Fecal Occult Testing

出版日
ページ情報
英文 281 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
便潜血検査の世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 281 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

便潜血検査の世界市場は2030年までに13億米ドルに達する

2024年に11億米ドルと推定される便潜血検査の世界市場は、分析期間2024-2030年にCAGR 3.8%で成長し、2030年には13億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるGuaiac FOB便検査は、CAGR 2.8%を記録し、分析期間終了時には4億8,860万米ドルに達すると予測されます。Immuno-FOB Agglutination Test（免疫-FOB凝集検査）分野の成長率は、分析期間中CAGR 4.6％と推定されます。

米国市場は2億9,310万米ドルと推定、中国はCAGR6.8％で成長予測

米国の便潜血検査市場は、2024年に2億9,310万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.8%として、2030年までに2億6,830万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.6%と2.9%と予測されています。欧州では、ドイツがCAGR 2.2%で成長すると予測されています。

世界の便潜血検査市場- 主要動向と促進要因のまとめ

便潜血検査が市場を牽引する理由病気の早期発見への注目の高まり

便潜血検査（FOBT）は、大腸がん、消化管（GI）障害、内出血を早期に発見するための重要な診断ツールとなりつつあります。大腸がん（CRC）、炎症性腸疾患（IBD）、消化管潰瘍の有病率の上昇により、非侵襲的で費用対効果が高く、迅速なスクリーニング方法の必要性が高まっており、病院、診断ラボ、家庭用検査キットでの便潜血検査の採用を促進しています。

技術革新は検査精度とアクセシビリティをどのように向上させているか？

免疫化学的便潜血検査（iFOBT）や高感度グアイアックベースFOBT（gFOBT）を含む最新の便潜血検査法は、より高い特異性、より迅速な結果、患者のコンプライアンス向上を提供します。さらに、AI主導の診断アルゴリズムと遠隔医療プラットフォームの統合により、遠隔検査、デジタル結果分析、AI支援による早期がん検診が可能になり、アクセシビリティがさらに向上しています。

政府の検診プログラムとヘルスケア政策は市場成長にどのような役割を果たすか？

WHO、CDC、European Cancer Prevention Networkを含む世界中の政府や保健機関は、便潜血検査を含む定期的なCRC検診プログラムを推進しています。日本、英国、カナダ、オーストラリアなど、医療政策が国営化されている国では、国民全体にFOBTスクリーニングを義務付けており、市場需要を大幅に押し上げています。

便潜血検査市場の成長の原動力は？

便潜血検査市場の成長は、大腸がん患者の増加、非侵襲的診断法の採用の増加、政府が支援するスクリーニングプログラムなど、複数の要因によってもたらされます。特に北米、欧州、日本における世界の高齢化は主要な促進要因であり、高齢者は大腸および胃腸疾患のリスクが高く、頻繁なFOBT検診が必要となるからです。さらに、遠隔医療と在宅診断ソリューションの拡大により、自己管理型FOBTキットがより利用しやすくなり、患者が病院や診療所を訪れることなく検査を実施できるようになっています。AI支援デジタル病理学とリキッドバイオプシー技術における革新は、検査感度と早期疾患検出精度をさらに高め、患者の転帰を改善し、ヘルスケアシステムの負担を軽減しています。さらに、主要ヘルスケア市場におけるCRC検診の償還政策の利用可能性の拡大は、患者の経済的障壁を下げ、検診率の向上を促しています。予防ヘルスケアへのシフトは、早期がん診断への投資の増加と相まって、今後も市場成長を牽引し、便潜血検査は世界の大腸がん予防戦略の要となると思われます。

セグメント

検査（Guaiac FOB Stool Test、Immuno-FOB Agglutination Test、Lateral Flow Immuno-FOB Test、Immuno-FOB ELISA Test）;エンドユース（病院エンドユース、診断センターエンドユース、その他エンドユース）

調査対象企業の例

  • Abbott Laboratories
  • Alfa Scientific Designs, Inc.
  • Beckman Coulter, Inc.（Danaher Corporation）
  • Biohit Oyj
  • Bio-Rad Laboratories, Inc.
  • EDP Biotech Corporation
  • Eiken Chemical Co., Ltd.
  • EIKEN CHEMICAL CO., LTD.
  • Epigenomics AG
  • Fujirebio Diagnostics, Inc.
  • Helena Laboratories Corporation
  • Meridian Bioscience, Inc.
  • Polymedco CDP, LLC
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Roche Diagnostics
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Wondfo Biotech Co., Ltd.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP30912

Global Fecal Occult Testing Market to Reach US$1.3 Billion by 2030

The global market for Fecal Occult Testing estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Guaiac FOB Stool Test, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$488.6 Million by the end of the analysis period. Growth in the Immuno-FOB Agglutination Test segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$293.1 Million While China is Forecast to Grow at 6.8% CAGR

The Fecal Occult Testing market in the U.S. is estimated at US$293.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$268.3 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Fecal Occult Testing Market - Key Trends & Drivers Summarized

Why Is Fecal Occult Testing Gaining Market Traction? The Growing Focus on Early Disease Detection

Fecal occult blood testing (FOBT) is becoming a key diagnostic tool for detecting colorectal cancer, gastrointestinal (GI) disorders, and internal bleeding at an early stage. The rising prevalence of colorectal cancer (CRC), inflammatory bowel disease (IBD), and gastrointestinal ulcers has heightened the need for non-invasive, cost-effective, and rapid screening methods, driving the adoption of fecal occult tests in hospitals, diagnostic laboratories, and at-home test kits.

How Are Technological Innovations Improving Test Accuracy & Accessibility?

Modern fecal occult testing methods, including immunochemical fecal occult blood tests (iFOBT) and high-sensitivity guaiac-based FOBT (gFOBT), offer higher specificity, faster results, and enhanced patient compliance. Additionally, the integration of AI-driven diagnostic algorithms and telemedicine platforms is enabling remote testing, digital result analysis, and AI-assisted early cancer screening, further enhancing accessibility.

What Role Do Government Screening Programs & Healthcare Policies Play in Market Growth?

Governments and health organizations worldwide, including the WHO, CDC, and European Cancer Prevention Network, are promoting routine CRC screening programs that include fecal occult blood testing. Countries with nationalized healthcare policies, such as Japan, the UK, Canada, and Australia, have mandated population-wide FOBT screenings, significantly boosting market demand.

What’s Driving the Growth of the Fecal Occult Testing Market?

The growth in the fecal occult testing market is driven by multiple factors, including rising colorectal cancer cases, increasing adoption of non-invasive diagnostics, and government-backed screening programs. The aging global population, particularly in North America, Europe, and Japan, is a major driver, as older adults are at a higher risk of colorectal and gastrointestinal diseases, necessitating frequent FOBT screenings. Additionally, the expansion of telehealth and at-home diagnostic solutions is making self-administered FOBT kits more accessible, allowing patients to conduct tests without visiting hospitals or clinics. Innovations in AI-assisted digital pathology and liquid biopsy techniques are further enhancing test sensitivity and early disease detection accuracy, ensuring better patient outcomes and reducing the burden on healthcare systems. Moreover, the growing availability of reimbursement policies for CRC screening in major healthcare markets is lowering financial barriers for patients, encouraging higher screening rates. The shift toward preventive healthcare, coupled with rising investments in early cancer diagnostics, will continue to drive market growth, making fecal occult testing a cornerstone of global colorectal cancer prevention strategies.

SCOPE OF STUDY:

The report analyzes the Fecal Occult Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test (Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test); End-Use (Hospital End-Use, Diagnostic Center End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Alfa Scientific Designs, Inc.
  • Beckman Coulter, Inc. (Danaher Corporation)
  • Biohit Oyj
  • Bio-Rad Laboratories, Inc.
  • EDP Biotech Corporation
  • Eiken Chemical Co., Ltd.
  • EIKEN CHEMICAL CO., LTD.
  • Epigenomics AG
  • Fujirebio Diagnostics, Inc.
  • Helena Laboratories Corporation
  • Meridian Bioscience, Inc.
  • Polymedco CDP, LLC
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Roche Diagnostics
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Wondfo Biotech Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Fecal Occult Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Emphasis on Early Colorectal Cancer Detection Drives Demand for Fecal Occult Testing
    • Public Health Screening Programs Propel Uptake of Non-Invasive Testing Technologies
    • Integration of Home-Based Testing Kits Expands Patient Participation in Screening Programs
    • Advancements in Immunochemical Testing Strengthen Accuracy and Adoption of FIT Methods
    • Favorable Reimbursement Policies Across Key Markets Expand Testing Accessibility
    • Aging Global Population Fuels Demand for Age-Specific Colorectal Cancer Screening Tools
    • Increased Awareness Through Government and NGO Campaigns Spurs Preventive Testing
    • Growing Use of Digital Health Platforms Enhances Test Distribution and Follow-Up Compliance
    • Expansion of Telehealth and Remote Monitoring Supports At-Home Sample Collection
    • Healthcare Cost-Containment Strategies Boost Adoption of Low-Cost Diagnostic Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fecal Occult Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fecal Occult Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fecal Occult Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Fecal Occult Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Guaiac FOB Stool Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Guaiac FOB Stool Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Guaiac FOB Stool Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immuno-FOB Agglutination Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Immuno-FOB Agglutination Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Immuno-FOB Agglutination Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Lateral Flow Immuno-FOB Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Lateral Flow Immuno-FOB Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Lateral Flow Immuno-FOB Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Immuno-FOB ELISA Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Immuno-FOB ELISA Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Immuno-FOB ELISA Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Center End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Center End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostic Center End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Fecal Occult Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Fecal Occult Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Fecal Occult Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Fecal Occult Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Fecal Occult Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Fecal Occult Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Fecal Occult Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Fecal Occult Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Fecal Occult Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Fecal Occult Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Fecal Occult Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Fecal Occult Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION